Global Patent Trends in Biologics Innovation

Advancements in biotechnology have made the large-scale development of biological drugs easier and more cost-effective to develop. While chemical-based drugs remain most prevalent, the total share of biologic drugs has increased significantly in recent years, representing more than 25% of the pharmaceutical market and more growth is expected with annual revenue to reach US$ 727 billion by 2025.

What does this growing trend mean for the industry at large? Download this whitepaper to learn more about:

  • The analysis of global patent activity as a predictor for biologics growth
  • Leading technology areas in biosequence patents
  • Acquiring Innovation: building versus buying
  • Top organizations leading biotechnology and biopharma innovation
  • Biotechnology hot spots around the globe